Prime Editing Creates Drug-Controllable T Cell Therapies

• October 28, 2026

Survival outcomes with Lutetium-177-PSMA-617 in metastatic castration-resistant prostate cancer patient according to baseline tumor characteristics

• by Mike Wenzel, Quynh Chi Le, Carolin Siech, Benedikt Hoeh, Konrad Klimek, Christian Happel, Fred Saad, Felix Preisser, Derya Tilki, Markus Graefen, Thomas Steuber, Tobias Maurer, Maximilian C. Kriegmair, Pierre I. Karakiewicz, Felix K. H. Chun, Daniel Groener, Philipp Mandel

• October 20, 2026

Allocation Policy Implementation During a Severe Chemotherapy Shortage

• by Eric C. Blackstone, Yating Wang, Eno-Abasi Inyang, Andrew G. Shuman, Michael Casey, Gregory A. Abel, Andrew Hantel

• October 19, 2026

Engineering CAR T Cells Inside Solid Tumors

Researchers develop targeted lipoplex platform that generates CAR T and NK cells directly within tumors, improving survival in preclinical breast cancer models

• October 26, 2026

• 3 min